Article disclosure (English):S.K. reports advisory-board fees from Abbvie, 89Bio, and Boehringer Ingelheim; an investigator-initiated Merck grant; and support for an industry-initiated Viking Therapeutics trial.
Educational evidence remains free. These summaries do not predict your response or change optimizer settings. Long-term cardiovascular outcomes and personal treatment decisions are outside this comparison.
Editorial review: · atlas-study-comparison/1; Declarations are not independent audits. · atlas-study-disclosures/1
How strong is this comparison?
One liver-fat question, three randomized trials with different interventions. Compare methods and missing data before interpreting direction.
Provisional method screen · not a formal RoB 2 or GRADE assessment
RCT
Petersen et al. · 2026
Comparison
Ketogenic vs Mediterranean vs very-low-fat; weight loss matched.
Includes methods, reported results, limits and source links. Provisional editorial screen; no clinical grade or winner.
No winner score. A non-significant difference does not prove equivalence.
Other evidence needs its own question: observational studies need confounding checks; meta-analyses need review and heterogeneity checks; animal studies can test mechanisms but need a bridge to human outcomes.
· atlas-liver-fat-methods/3
Knowledge-pack provenance
Signed food-data pack: atlas-usda-composition-5e9c608795c66aba